| Ms Janice Kirstine Hammond, CNM | |
|
200 W Coolidge Ave, Modesto, CA 95350-4447 | |
| (209) 577-5005 | |
| (209) 521-1533 |
| Full Name | Ms Janice Kirstine Hammond |
|---|---|
| Gender | Female |
| Speciality | Advanced Practice Midwife |
| Location | 200 W Coolidge Ave, Modesto, California |
| Accepts Medicare Assignments | Does not participate in Medicare Program. She may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1154537256 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 367A00000X | Advanced Practice Midwife | CNMW-178 (California) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| Ms Janice Kirstine Hammond, CNM 200 W Coolidge Ave, Modesto, CA 95350-4447 Ph: (209) 577-5005 | Ms Janice Kirstine Hammond, CNM 200 W Coolidge Ave, Modesto, CA 95350-4447 Ph: (209) 577-5005 |
News Archive
A promising new molecular imaging technique may provide physicians and patients with a noninvasive way to learn more information about a type of cancer of the uterus lining called "endometrial carcinoma"-one of the most common malignant female tumors. This research was presented in a study published in the October issue of The Journal of Nuclear Medicine.
Lung cancer impacts the lives of millions of people worldwide. In nearly 40 percent of people diagnosed with lung cancer, it has metastasized, or spread to other areas of the body, making it difficult to treat. Immunotherapy is a type of therapy that uses the body's own immune system to help fight cancer. Immunotherapy may help the body's immune system target cancer cells.
King Pharmaceuticals, Inc. announced today that total revenues were $463 million during the third quarter ended September 30, 2009, compared to $388 million in the third quarter of 2008. The Company reported net income of $42 million and diluted earnings per share of $0.17 during the third quarter of 2009, compared to net income of $82 million and diluted earnings per share of $0.34 in the third quarter of the prior year.
Bristol-Myers Squibb Company and Pfizer today announced that the companies are planning to submit an application for regulatory approval of apixaban in Europe for the prevention of venous thromboembolism (VTE) after orthopedic surgery in the first half of 2010.
› Verified 8 days ago
Blanca E. Zank, R.N. C.N.M. Advanced Practice Midwife Medicare: Medicare Enrolled Practice Location: 1400 Florida Ave, Ste. 207, Modesto, CA 95350 Phone: 209-522-1027 Fax: 209-522-7956 | |
Irene Belle Feaver, R.N. C.N.M. Advanced Practice Midwife Medicare: Medicare Enrolled Practice Location: 1400 Florida Ave, Ste. 207, Modesto, CA 95350 Phone: 209-522-1027 Fax: 209-522-7956 | |
Alyssia Joan Suess, CNM Advanced Practice Midwife Medicare: Not Enrolled in Medicare Practice Location: 4601 Dale Rd, Modesto, CA 95356 Phone: 209-735-5000 | |
Mrs. Jocelyn Sanders, CNM/WHNP Advanced Practice Midwife Medicare: Medicare Enrolled Practice Location: 4601 Dale Rd, Modesto, CA 95356 Phone: 209-735-5000 | |
Jennifer Joyce Currie, C.N.M. Advanced Practice Midwife Medicare: Medicare Enrolled Practice Location: 1444 Florida Ave, Ste. 101, Modesto, CA 95350 Phone: 209-522-1027 Fax: 209-522-7956 | |
Shawna Marie Garguile, C.N.M. Advanced Practice Midwife Medicare: Medicare Enrolled Practice Location: 4601 Dale Rd, Modesto, CA 95356 Phone: 209-735-5828 |